Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: second revenue stream in the bag ??

second revenue stream in the bag ??

posted on Sep 12, 2007 05:42PM

Turley's interview sounds as though he not only has his mind made up of what we are going to get into, but that it is already being put into place.

 "We intendto do that either through acquisition or throughR&D or some combination of those. And it’s goingto be soon; it’s going to be, I think, in the next 12to 18 months when we’ll show the world what oursecond product line is."

 16,000 shareholders,none of whom holds more than about 8% of the company (very interesting !)

.got it pretty well figured out.

Share
New Message
Please login to post a reply